Biosinc (Jinan) Chemical & Pharmaceutical Co., Ltd.

Pyridine,2-(chloromethyl)-3,4-dimethoxy-,hydrochloride (1:1);Pyridine,2-(chloromethyl)-3,4-dimethoxy-,hydrochloride;2-(Chloromethyl)-3,4-dimethoxypyridine hydrochloride;3,4-Dimethoxy-2-chloromethylpyridine hydrochloride

2H-Benzimidazole-2-thione,5-(difluoromethoxy)-1,3-dihydro-;5-(Difluoromethoxy)-1,3-dihydro-2H-benzimidazole-2-thione;5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole;5-Difluoromethoxy-2-mercaptobenzimidazole;2-Mercapto-5-difluoromethoxy-1H-benzimidazole;SKA 47

5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium,6-[[(4R,5S,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-,inner salt;5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium,6-[[2-carboxy-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-,inner salt,[4R-[4α,5β,6β(R*)]]-;1-Azabicyclo[3.2.0]heptane,5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium deriv.;LJC 10627;L 627;6-[[(4R,5S,6S)-2-Carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a]-s-triazol-4-ium hydroxide,inner salt;CL 186815;Biapenem;Biapenern;CL 186-815;Omegacin;103939-78-2;133279-57-9

Ergotaman-3′,6′,18-trione,2-bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-,(5α)-,methanesulfonate (1:1);Ergocryptine,2-bromo-,monomethanesulfonate (salt);Ergotaman-3′,6′,18-trione,2-bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-,(5′α)-,monomethanesulfonate (salt);Indolo[4,3-fg]quinoline,ergotaman-3′,6′,18-trione deriv.;8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine,ergotaman-3′,6′,18-trione deriv.;Bromocriptine mesylate;Bromocriptine methanesulfonate;Parlodel;Bromocryptine mesylate;CB 154;Bromocryptine methanesulfonate;Pravidel;Bagren;(+)-Bromocriptine methanesulfonate;Cycloset;127931-10-6;25614-04-4;35925-33-8;58181-56-9;71185-16-5

Adenosine,N-(1-oxobutyl)-,cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate;Butyramide,N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-,cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate;Butyramide,N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-,2′-butyrate,cyclic 3′,5′-phosphate;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.;Cyclic AMP N6,2′-O-dibutyrate;N6,2′-O-Dibutyryladenosine cyclic 3′,5′-monophosphate;N6,2′-O-Dibutyryl cyclic 3′,5′-adenosine monophosphate;Dibutyryl cyclic adenosine monophosphate;Dibutyryl cyclic 3′,5′-AMP;Dibutyryl 3′,5′-cyclic adenosine monophosphate;N6,2′-Dibutyryladenosine cyclic 3′,5′-(hydrogen phosphate);Dibutyryl 3′,5′-cyclic AMP;Dibutyryl cyclic AMP;N6,O2′-Dibutyrylcyclic adenosine 3′,5′-phosphate;Dibutyryl cyclic 3′,5′-adenylic acid;Dibutyryl-3′,5′-adenosine monophosphate;N6,2′-O-Dibutyryl 3′,5′-cyclic adenosine monophosphate;N6,2′-O-Dibutyryladenosine 3′,5′-monophosphate;Dibutyryladenosine 3′,5′-monophosphate;Dibutyryl cyclic adenosine 3′,5′-monophosphate;N6,O2′-Dibutyryl cyclic AMP;N6,O2′-Dibutyryl adenosine-3′,5′-phosphate;N6,O2′-Dibutyryl cyclic 3′,5′-AMP;N6,O2′-Dibutyryl 3′,5′-AMP;Dibutyryladenosine cyclic 3′,5′-monophosphate;Dibutyryladenosine 3′,5′-cyclic phosphate;Dibutyryladenosine cyclic monophosphate;Dibutyryladenosine 3′,5′-cyclic monophosphate;Dibutyryl-3′,5′-AMP;N6,2′-O-Dibutyryl cyclic AMP;N6-2′-O-Dibutyryl-3′,5′-AMP;130715-01-4;633313-87-8;251294-71-0

Ergoline-8-carboxamide,N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)-,(8β)-;Ergoline-8-carboxamide,N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-,(8β)-;(8β)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)ergoline-8-carboxamide;Cabergoline;Sogilen;Dostinex;Cabaser;Galastop;Cabaseril;Velactis

Adenosine,cyclic 3′,5′-(hydrogen phosphate);Adenosine 3′,5′-cyclic phosphate;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.;3′,5′-AMP;Adenosine cyclic 3′,5′-monophosphate;Adenosine 3′,5′-cyclophosphate;Adenosine 3′,5′-monophosphate;Adenosine 3′,5′-phosphate;Cyclic adenosine 3′,5′-phosphate;Cyclic 3′,5′-adenylic acid;Cyclic 3′,5′-monophosphate adenosine;Cyclic-3′,5′-phosphate adenosine;Cyclic AMP;Cyclic adenosine 3′,5′-monophosphate;Cyclic 3′,5′-AMP;cAMP;Adenosine cyclic monophosphate;NSC 143670;NSC 94017;AMPc;NQZ-026;11002-78-1

Ergoline-8-methanol,10-methoxy-1,6-dimethyl-,8-(5-bromo-3-pyridinecarboxylate),(8β)-;Ergoline-8β-methanol,10-methoxy-1,6-dimethyl-,5-bromonicotinate (ester);Ergoline-8-methanol,10-methoxy-1,6-dimethyl-,5-bromo-3-pyridinecarboxylate (ester),(8β)-;Nicotinic acid,5-bromo-,(10-methoxy-1,6-dimethylergolin-8β-yl)methyl ester;Indolo[4,3-fg]quinoline,ergoline-8-methanol deriv.;MNE;Nicotergoline;1,6-Dimethyl-8β-(5-bromonicotinoyloxymethyl)-10α-methoxyergoline;Nicergoline;Sermion;TA 079;Ergotop;Ergobel;Cergodum;Circo-Maren;Duracebrol;Vasospan;Memoq;Nicergolent;FI 6714;Dilasenil;NSC 150531;24705-56-4;37415-54-6;47673-09-6

4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,hydrochloride,hydrate (1:1:2);4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,monohydrochloride,dihydrate;Ondansetron hydrochloride dihydrate

1H-Benzimidazole,6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-;1H-Benzimidazole,5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-;6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;Pantoprazole;SKF 96022;BY 1023;5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole;5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;Pantozol;(±)-Pantoprazole;2-[[(3,4-Dimethoxypyridin-2-yl)methyl]sulfinyl]-5-difluoromethoxy-1H-benzimidazole;Pantocid;Protium;Protium (pharmaceutical);Zovanta;Altopan;Pantopan;Pantecta Control;Pantoloc Control;Pantozol Control;Somac Control;Controloc Control;154644-14-1

5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium,6,7-dihydro-6-mercapto-,chloride (1:1);5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium,6,7-dihydro-6-mercapto-,chloride